SlideShare ist ein Scribd-Unternehmen logo
1 von 21
Antipsychotics I
Brian J. Piper, Ph.D., M.S.
   piperbj@husson.edu




                February 4, 2013
Goals
• Pharmacy students
  should:
  – be familiar with the
    symptoms & health
    consequences of
    schizophrenia
  – be able to describe the
    mechanism(s) of action
    and adverse effects of first-
    generation antipsychotics
Schizophrenia

The Greek translation is schizein “split” and phren
“mind” which refers to a split from reality. A group
of severe disorders characterized by atypical:
          1. Cognition
          2. Behavior
          3. Emotions                NOT Multiple Personality
                                     Disorder
Symptoms of Schizophrenia
Positive symptoms: the presence of inappropriate
behaviors
      delusions: thoughts
      hallucinations: auditory >>> visual > other
      disorganized talking: “word salad”
      movements

Negative symptoms: the absence of appropriate
behaviors
      flat affect: joy, anger, disgust
      anhedonia
      catatonia: waxy flexibility
Example Patient
Delusions of grandeur
inappropriate beliefs about
one’s self-worth or special
powers




Gerald (upto 2:30): http://www.youtube.com/watch?v=gGnl8dqEoPQ
Epidemiology of
                  Schizophrenia


 Frequency: 0.7%
 Sex: Males > Females (1.4:1) in # and severity
 Low SES (downward drift)
 Rule of thirds
 Comorbidity with depression & smoking




Sources: Anna K. Kring
History of Antipsychotics
• 1953: an antihistamine agent (cholpromazine) is found to
  improve psychosis in schizophrenics
• 1960-1970: identification of D2 blockade as the key
  mechanism, development of these first-generation of
  antipsychotic agents
Dopamine System I
• nigrostriatal: substania nigra (soma) to striatum (axons)




Stahl, S. (2008). Essential Psychopharmacology, p. 330.
Antipsychotics & Tardive Dyskinesia




 Chronic blockade of D2 receptors leads                This may cause involuntary movements.
 them to up-regulate.

  tardive: slow or belated onset
  dyskinesia: presence of involuntary movements, tongue thrusts, lip smacking, eye blinking

  Potentially permanent!

Example: 4:20 to 5:50: http://www.youtube.com/watch?v=QYYx1mZDpPw
TD = Extrapyramidal Symptoms (Long-Term)




Brodal (2010). The central nervous system. p. 83.
Extrapyramidal Symptoms (Short-term)
   • Pseudo-Parkinsonism:
        – tremor
        – rigidity
        – bradykinesia
   • dystonia: involuntary muscle spasms
        – torticollis: abnormal head or neck position
   • akathisia: severe sensation of
     restlessness, strong desire to move


Excellent Examples (0:30- 4:50-9:15): http://www.youtube.com/watch?v=WAg2iLEWVh0
Dopamine Inhibits Acetylcholine




Stahl, S. (2008). Essential Psychopharmacology, p. 338.
D2 Inhibition & Increased ACh




Stahl, S. (2008). Essential Psychopharmacology, p. 339.
Solution: Anti-cholinergics




Stahl, S. (2008). Essential Psychopharmacology, p. 339.
Dopamine Inhibits Prolactin



                                                          Consequences
                                                          amenorrhea
                                                          galactorhea
                                                          ↓ sex interest
                                                          gynecomastia




Stahl, S. (2008). Essential Psychopharmacology, p. 334.
Dopamine & Mood

• Dopamine projections to nucleus accumbens
• Increasing dopamine increases reward
• anti-psychotics block this pathway
Non-Selectivity of FGA




Stahl, S. (2008). Essential Psychopharmacology, p. 338, 340.
Haloperidol

• MOA: D2 antagonist, α1 antagonist
• Indications: acute psychosis/schizophrenia
• Adverse Effects: extrapyramidal symptoms
  (EPS), hypotension
Summary: Pros & Cons
  • FGAs have strong efficacy against + symptoms.
  • FGAs either do not help – symptoms or exacerbate them.
  • The primary concern with FGAs is long-term development of
    tardive dyskinesia although acute EPS impair the quality of
    life of schizophrenics.




Stahl, S. (2008). Essential Psychopharmacology, p. 369.
Terminology
• Neuroleptic = major tranquilizer =
  antipsychotic
• First Generation Antipsychotic = Typical =
  Conventional
Reduced Lifespan
           (N = 5,036,662)

                   Male              Male         Female                  Female
                   Life Expectancy   Years        Life                    Years Lost
                                     Lost         Expectancy
All (Psychiatric   76.5              NA           80.9                    NA
History - )
Schizophrenia      57.8              18.7         64.6                    16.3
Bipolar            62.9              13.6         68.8                    12.1


                                       Contributing Factors
                                       suicide, accident, homicides,
                                       self-care (diet/smoking), metabolic (?)


                                            Laursen (2011). Schizophrenia Research, 131, 101-104.

Weitere ähnliche Inhalte

Was ist angesagt?

SEROTONIN (5-HT) NEUROTRANSMITTER
SEROTONIN (5-HT) NEUROTRANSMITTER �SEROTONIN (5-HT) NEUROTRANSMITTER �
SEROTONIN (5-HT) NEUROTRANSMITTER Aminu Kende
 
Anti-Parkinsonism Drugs / Drugs Used in the treatment of Parkinson's Disease
Anti-Parkinsonism Drugs / Drugs Used in the treatment of Parkinson's DiseaseAnti-Parkinsonism Drugs / Drugs Used in the treatment of Parkinson's Disease
Anti-Parkinsonism Drugs / Drugs Used in the treatment of Parkinson's DiseaseKameshwaran Sugavanam
 
Pharmacology of dopamine
Pharmacology of dopaminePharmacology of dopamine
Pharmacology of dopaminesumitwankh
 
anti-psychotic drugs
anti-psychotic drugsanti-psychotic drugs
anti-psychotic drugsDJ CrissCross
 
Pharmacology - Parkinsonism
Pharmacology - ParkinsonismPharmacology - Parkinsonism
Pharmacology - ParkinsonismMBBS IMS MSU
 
Antidepressants -pharmacology
Antidepressants -pharmacologyAntidepressants -pharmacology
Antidepressants -pharmacologypavithra vinayak
 
Mao ; mao inhibitors
Mao ; mao inhibitorsMao ; mao inhibitors
Mao ; mao inhibitorsAbhijithSP6
 
Nature of psychosis and schizophrenia
Nature of psychosis and schizophreniaNature of psychosis and schizophrenia
Nature of psychosis and schizophreniaDomina Petric
 
CNS stimulants - Parmacology
CNS stimulants - ParmacologyCNS stimulants - Parmacology
CNS stimulants - ParmacologyAreej Abu Hanieh
 
Pathophysiology of anxiety
Pathophysiology of anxietyPathophysiology of anxiety
Pathophysiology of anxietyMirza Anwar Baig
 
Classification of Antidepressants & “Diagnosis & Pathophysiology of Depression”
Classification of Antidepressants & “Diagnosis & Pathophysiology of Depression”Classification of Antidepressants & “Diagnosis & Pathophysiology of Depression”
Classification of Antidepressants & “Diagnosis & Pathophysiology of Depression”Sawsan Aboul-Fotouh
 

Was ist angesagt? (20)

Antidepressant drugs
Antidepressant drugsAntidepressant drugs
Antidepressant drugs
 
SEROTONIN (5-HT) NEUROTRANSMITTER
SEROTONIN (5-HT) NEUROTRANSMITTER �SEROTONIN (5-HT) NEUROTRANSMITTER �
SEROTONIN (5-HT) NEUROTRANSMITTER
 
Anti-Parkinsonism Drugs / Drugs Used in the treatment of Parkinson's Disease
Anti-Parkinsonism Drugs / Drugs Used in the treatment of Parkinson's DiseaseAnti-Parkinsonism Drugs / Drugs Used in the treatment of Parkinson's Disease
Anti-Parkinsonism Drugs / Drugs Used in the treatment of Parkinson's Disease
 
ANTIDEPRESSANTS
ANTIDEPRESSANTSANTIDEPRESSANTS
ANTIDEPRESSANTS
 
Anti-epileptic drugs
Anti-epileptic drugsAnti-epileptic drugs
Anti-epileptic drugs
 
Pharmacology of dopamine
Pharmacology of dopaminePharmacology of dopamine
Pharmacology of dopamine
 
anti-psychotic drugs
anti-psychotic drugsanti-psychotic drugs
anti-psychotic drugs
 
Sedatives & hypnotics
Sedatives & hypnoticsSedatives & hypnotics
Sedatives & hypnotics
 
Pharmacology - Parkinsonism
Pharmacology - ParkinsonismPharmacology - Parkinsonism
Pharmacology - Parkinsonism
 
Antidepressants -pharmacology
Antidepressants -pharmacologyAntidepressants -pharmacology
Antidepressants -pharmacology
 
Mao ; mao inhibitors
Mao ; mao inhibitorsMao ; mao inhibitors
Mao ; mao inhibitors
 
Antipsychotics
AntipsychoticsAntipsychotics
Antipsychotics
 
Sedative and hypnotics
Sedative and hypnoticsSedative and hypnotics
Sedative and hypnotics
 
Nature of psychosis and schizophrenia
Nature of psychosis and schizophreniaNature of psychosis and schizophrenia
Nature of psychosis and schizophrenia
 
Levodopa+carbidopa
Levodopa+carbidopaLevodopa+carbidopa
Levodopa+carbidopa
 
Serotonin
SerotoninSerotonin
Serotonin
 
CNS stimulants - Parmacology
CNS stimulants - ParmacologyCNS stimulants - Parmacology
CNS stimulants - Parmacology
 
Pathophysiology of anxiety
Pathophysiology of anxietyPathophysiology of anxiety
Pathophysiology of anxiety
 
Classification of Antidepressants & “Diagnosis & Pathophysiology of Depression”
Classification of Antidepressants & “Diagnosis & Pathophysiology of Depression”Classification of Antidepressants & “Diagnosis & Pathophysiology of Depression”
Classification of Antidepressants & “Diagnosis & Pathophysiology of Depression”
 
Antidepressants
AntidepressantsAntidepressants
Antidepressants
 

Andere mochten auch

Antipsychotics
AntipsychoticsAntipsychotics
Antipsychoticsraj kumar
 
Schizophrenia and Antipsychotic Drugs
Schizophrenia and Antipsychotic DrugsSchizophrenia and Antipsychotic Drugs
Schizophrenia and Antipsychotic DrugsFarazaJaved
 
Antipsychotic : Dr Rahul Kunkulol's Power point preparations
Antipsychotic : Dr Rahul Kunkulol's Power point preparationsAntipsychotic : Dr Rahul Kunkulol's Power point preparations
Antipsychotic : Dr Rahul Kunkulol's Power point preparationsRahul Kunkulol
 
Antipsychotics Part II
Antipsychotics Part IIAntipsychotics Part II
Antipsychotics Part IIBrian Piper
 
Neuroleptics (antipsychotics)
Neuroleptics (antipsychotics)Neuroleptics (antipsychotics)
Neuroleptics (antipsychotics)Mohsin Aziz
 
Overview of the Mechanism of Typical vs Atypical Antipsychotics
Overview of the Mechanism of Typical vs Atypical AntipsychoticsOverview of the Mechanism of Typical vs Atypical Antipsychotics
Overview of the Mechanism of Typical vs Atypical AntipsychoticsChristiane Riedinger
 
Atypical antipsychotics
Atypical antipsychoticsAtypical antipsychotics
Atypical antipsychoticsKarrar Husain
 
Typical antipsychotics
Typical   antipsychoticsTypical   antipsychotics
Typical antipsychoticsAnant Rathi
 
Antidepressants powerpoint
Antidepressants powerpointAntidepressants powerpoint
Antidepressants powerpointAllegra Lange
 
Mental disorders
Mental disordersMental disorders
Mental disorderskatelync
 
Classification of Psychiatric disorders
Classification of Psychiatric disordersClassification of Psychiatric disorders
Classification of Psychiatric disordersdonthuraj
 
Copy Of October 6 Rationale
Copy Of October 6 RationaleCopy Of October 6 Rationale
Copy Of October 6 RationalePeak Review/FSUU
 
Thesis_Status_of_Population_Structure_Size_and_Distribution_of_Prunus_african...
Thesis_Status_of_Population_Structure_Size_and_Distribution_of_Prunus_african...Thesis_Status_of_Population_Structure_Size_and_Distribution_of_Prunus_african...
Thesis_Status_of_Population_Structure_Size_and_Distribution_of_Prunus_african...Hillary koros
 

Andere mochten auch (20)

Antipsychotic drugs
Antipsychotic drugsAntipsychotic drugs
Antipsychotic drugs
 
Antipsychotics
AntipsychoticsAntipsychotics
Antipsychotics
 
Antipsychotics - drdhriti
Antipsychotics - drdhritiAntipsychotics - drdhriti
Antipsychotics - drdhriti
 
Antipsychotics
AntipsychoticsAntipsychotics
Antipsychotics
 
Schizophrenia and Antipsychotic Drugs
Schizophrenia and Antipsychotic DrugsSchizophrenia and Antipsychotic Drugs
Schizophrenia and Antipsychotic Drugs
 
Antipsychotic : Dr Rahul Kunkulol's Power point preparations
Antipsychotic : Dr Rahul Kunkulol's Power point preparationsAntipsychotic : Dr Rahul Kunkulol's Power point preparations
Antipsychotic : Dr Rahul Kunkulol's Power point preparations
 
Antipsychotics Part II
Antipsychotics Part IIAntipsychotics Part II
Antipsychotics Part II
 
Neuroleptics (antipsychotics)
Neuroleptics (antipsychotics)Neuroleptics (antipsychotics)
Neuroleptics (antipsychotics)
 
Overview of the Mechanism of Typical vs Atypical Antipsychotics
Overview of the Mechanism of Typical vs Atypical AntipsychoticsOverview of the Mechanism of Typical vs Atypical Antipsychotics
Overview of the Mechanism of Typical vs Atypical Antipsychotics
 
Atypical antipsychotics
Atypical antipsychoticsAtypical antipsychotics
Atypical antipsychotics
 
Iloperidone
Iloperidone Iloperidone
Iloperidone
 
Typical antipsychotics
Typical   antipsychoticsTypical   antipsychotics
Typical antipsychotics
 
Atypical antipsychotics
Atypical antipsychoticsAtypical antipsychotics
Atypical antipsychotics
 
Mood stabilizers
Mood stabilizersMood stabilizers
Mood stabilizers
 
Antidepressants powerpoint
Antidepressants powerpointAntidepressants powerpoint
Antidepressants powerpoint
 
Mental disorders
Mental disordersMental disorders
Mental disorders
 
ANTIDEPRESSANTS
ANTIDEPRESSANTSANTIDEPRESSANTS
ANTIDEPRESSANTS
 
Classification of Psychiatric disorders
Classification of Psychiatric disordersClassification of Psychiatric disorders
Classification of Psychiatric disorders
 
Copy Of October 6 Rationale
Copy Of October 6 RationaleCopy Of October 6 Rationale
Copy Of October 6 Rationale
 
Thesis_Status_of_Population_Structure_Size_and_Distribution_of_Prunus_african...
Thesis_Status_of_Population_Structure_Size_and_Distribution_of_Prunus_african...Thesis_Status_of_Population_Structure_Size_and_Distribution_of_Prunus_african...
Thesis_Status_of_Population_Structure_Size_and_Distribution_of_Prunus_african...
 

Ähnlich wie Antipsychotics I

Negative symptoms of Schizophrenia
Negative symptoms of SchizophreniaNegative symptoms of Schizophrenia
Negative symptoms of Schizophreniadassoumitradr
 
Schizophrenia; understanding and issues
Schizophrenia; understanding and issuesSchizophrenia; understanding and issues
Schizophrenia; understanding and issuesSushma Rathee
 
Schizophrenia - Renu.s
Schizophrenia - Renu.sSchizophrenia - Renu.s
Schizophrenia - Renu.sRENUSANTHAMMA
 
Schizophrenia:- Current approaches for the treatment
Schizophrenia:- Current approaches for the treatment Schizophrenia:- Current approaches for the treatment
Schizophrenia:- Current approaches for the treatment Drx Avtar Singh
 
Schizophrenia & other psychotic disorder
Schizophrenia & other psychotic disorderSchizophrenia & other psychotic disorder
Schizophrenia & other psychotic disorderHussein Ali Ramadhan
 
Practical Issues In Schizophrenia
Practical Issues In SchizophreniaPractical Issues In Schizophrenia
Practical Issues In SchizophreniaPk Doctors
 
Practical issues in schizophrenia
Practical issues in schizophreniaPractical issues in schizophrenia
Practical issues in schizophreniaPk Doctors
 
Antidepressants Part I
Antidepressants Part IAntidepressants Part I
Antidepressants Part IBrian Piper
 
45304607-Schizophrenia.pptx
45304607-Schizophrenia.pptx45304607-Schizophrenia.pptx
45304607-Schizophrenia.pptxAkshayWankhede14
 
Typical antipsychotics and dopamine in psychosis
Typical antipsychotics and dopamine in psychosis Typical antipsychotics and dopamine in psychosis
Typical antipsychotics and dopamine in psychosis Ann Sparks
 
/Users/martin/desktop/psychoticdisorders
/Users/martin/desktop/psychoticdisorders/Users/martin/desktop/psychoticdisorders
/Users/martin/desktop/psychoticdisorderszsyaseen
 
Nursing management of patient with schizophrenia and other psychotic disorder
Nursing management of patient with schizophrenia and other psychotic disorderNursing management of patient with schizophrenia and other psychotic disorder
Nursing management of patient with schizophrenia and other psychotic disorderRupaliwalke22
 
Schizophrenia- biological and neuropsychological approacesh
Schizophrenia- biological and neuropsychological approaceshSchizophrenia- biological and neuropsychological approacesh
Schizophrenia- biological and neuropsychological approaceshPriya Puri
 

Ähnlich wie Antipsychotics I (20)

Schizophrenia
SchizophreniaSchizophrenia
Schizophrenia
 
Negative symptoms of Schizophrenia
Negative symptoms of SchizophreniaNegative symptoms of Schizophrenia
Negative symptoms of Schizophrenia
 
Schizophrenia; understanding and issues
Schizophrenia; understanding and issuesSchizophrenia; understanding and issues
Schizophrenia; understanding and issues
 
schizophrenia
schizophreniaschizophrenia
schizophrenia
 
Schizophrenia - Renu.s
Schizophrenia - Renu.sSchizophrenia - Renu.s
Schizophrenia - Renu.s
 
Schizophrenia:- Current approaches for the treatment
Schizophrenia:- Current approaches for the treatment Schizophrenia:- Current approaches for the treatment
Schizophrenia:- Current approaches for the treatment
 
Q2 lo4 schizophrenia
Q2 lo4   schizophreniaQ2 lo4   schizophrenia
Q2 lo4 schizophrenia
 
Q2 L04 - Schizophrenia
Q2 L04  - SchizophreniaQ2 L04  - Schizophrenia
Q2 L04 - Schizophrenia
 
Q2 L04 - Schizophrenia
Q2 L04  - SchizophreniaQ2 L04  - Schizophrenia
Q2 L04 - Schizophrenia
 
Schizophrenia.ppt psy od d/h
Schizophrenia.ppt psy od  d/hSchizophrenia.ppt psy od  d/h
Schizophrenia.ppt psy od d/h
 
Schizophrenia & other psychotic disorder
Schizophrenia & other psychotic disorderSchizophrenia & other psychotic disorder
Schizophrenia & other psychotic disorder
 
Practical Issues In Schizophrenia
Practical Issues In SchizophreniaPractical Issues In Schizophrenia
Practical Issues In Schizophrenia
 
Practical issues in schizophrenia
Practical issues in schizophreniaPractical issues in schizophrenia
Practical issues in schizophrenia
 
Antidepressants Part I
Antidepressants Part IAntidepressants Part I
Antidepressants Part I
 
45304607-Schizophrenia.pptx
45304607-Schizophrenia.pptx45304607-Schizophrenia.pptx
45304607-Schizophrenia.pptx
 
Typical antipsychotics and dopamine in psychosis
Typical antipsychotics and dopamine in psychosis Typical antipsychotics and dopamine in psychosis
Typical antipsychotics and dopamine in psychosis
 
Schizophrenia ppt
Schizophrenia pptSchizophrenia ppt
Schizophrenia ppt
 
/Users/martin/desktop/psychoticdisorders
/Users/martin/desktop/psychoticdisorders/Users/martin/desktop/psychoticdisorders
/Users/martin/desktop/psychoticdisorders
 
Nursing management of patient with schizophrenia and other psychotic disorder
Nursing management of patient with schizophrenia and other psychotic disorderNursing management of patient with schizophrenia and other psychotic disorder
Nursing management of patient with schizophrenia and other psychotic disorder
 
Schizophrenia- biological and neuropsychological approacesh
Schizophrenia- biological and neuropsychological approaceshSchizophrenia- biological and neuropsychological approacesh
Schizophrenia- biological and neuropsychological approacesh
 

Mehr von Brian Piper

Current recreational drugs: RX462 Drug Abuse & Society, Spring 2015 Class pre...
Current recreational drugs: RX462 Drug Abuse & Society, Spring 2015 Class pre...Current recreational drugs: RX462 Drug Abuse & Society, Spring 2015 Class pre...
Current recreational drugs: RX462 Drug Abuse & Society, Spring 2015 Class pre...Brian Piper
 
Drug Abuse & Society (RX 462) Presentations-Spring 2014
Drug Abuse & Society (RX 462) Presentations-Spring 2014Drug Abuse & Society (RX 462) Presentations-Spring 2014
Drug Abuse & Society (RX 462) Presentations-Spring 2014Brian Piper
 
electronic cigarettes
electronic cigaretteselectronic cigarettes
electronic cigarettesBrian Piper
 
Examination of Sexually Dimorphic Behavior on the Novel-Image Novel-Location ...
Examination of Sexually Dimorphic Behavior on the Novel-Image Novel-Location ...Examination of Sexually Dimorphic Behavior on the Novel-Image Novel-Location ...
Examination of Sexually Dimorphic Behavior on the Novel-Image Novel-Location ...Brian Piper
 
Drug abuse and society drug presentations: Spring 2013
Drug abuse and society drug presentations: Spring 2013Drug abuse and society drug presentations: Spring 2013
Drug abuse and society drug presentations: Spring 2013Brian Piper
 
Sedative & Hypnotic Drugs Part II
Sedative & Hypnotic Drugs Part IISedative & Hypnotic Drugs Part II
Sedative & Hypnotic Drugs Part IIBrian Piper
 
Sedative & Hypnotic Agents Part I
Sedative & Hypnotic Agents Part ISedative & Hypnotic Agents Part I
Sedative & Hypnotic Agents Part IBrian Piper
 
Agents for Bipolar
Agents for BipolarAgents for Bipolar
Agents for BipolarBrian Piper
 
Psychopharmacology of Anxiety: Part II OCD & PTSD
Psychopharmacology of Anxiety: Part II OCD & PTSDPsychopharmacology of Anxiety: Part II OCD & PTSD
Psychopharmacology of Anxiety: Part II OCD & PTSDBrian Piper
 
Psychopharmacology of Anxiety Disorders I: GAD & SAD
Psychopharmacology of Anxiety Disorders I: GAD & SADPsychopharmacology of Anxiety Disorders I: GAD & SAD
Psychopharmacology of Anxiety Disorders I: GAD & SADBrian Piper
 
Anti Inflammation agents for CNS
Anti Inflammation agents for CNSAnti Inflammation agents for CNS
Anti Inflammation agents for CNSBrian Piper
 
Antidepressants Part II
Antidepressants Part IIAntidepressants Part II
Antidepressants Part IIBrian Piper
 
Anticonvulsants Part II
Anticonvulsants Part IIAnticonvulsants Part II
Anticonvulsants Part IIBrian Piper
 
Anticonvulsants Part I
Anticonvulsants Part IAnticonvulsants Part I
Anticonvulsants Part IBrian Piper
 
Agents for Brain Injury
Agents for Brain InjuryAgents for Brain Injury
Agents for Brain InjuryBrian Piper
 
Pathophysiology: Myasthenia Gravis & Restless Leg Syndrome
Pathophysiology: Myasthenia Gravis & Restless Leg SyndromePathophysiology: Myasthenia Gravis & Restless Leg Syndrome
Pathophysiology: Myasthenia Gravis & Restless Leg SyndromeBrian Piper
 
Pathophysiology: Migraine & Headache
Pathophysiology: Migraine & HeadachePathophysiology: Migraine & Headache
Pathophysiology: Migraine & HeadacheBrian Piper
 
Pathophysiology: Alzheimer's Disease
Pathophysiology: Alzheimer's DiseasePathophysiology: Alzheimer's Disease
Pathophysiology: Alzheimer's DiseaseBrian Piper
 
Pathophysiology: Introduction to Neuropsychiatry
Pathophysiology: Introduction to Neuropsychiatry Pathophysiology: Introduction to Neuropsychiatry
Pathophysiology: Introduction to Neuropsychiatry Brian Piper
 

Mehr von Brian Piper (20)

Current recreational drugs: RX462 Drug Abuse & Society, Spring 2015 Class pre...
Current recreational drugs: RX462 Drug Abuse & Society, Spring 2015 Class pre...Current recreational drugs: RX462 Drug Abuse & Society, Spring 2015 Class pre...
Current recreational drugs: RX462 Drug Abuse & Society, Spring 2015 Class pre...
 
Drug Abuse & Society (RX 462) Presentations-Spring 2014
Drug Abuse & Society (RX 462) Presentations-Spring 2014Drug Abuse & Society (RX 462) Presentations-Spring 2014
Drug Abuse & Society (RX 462) Presentations-Spring 2014
 
electronic cigarettes
electronic cigaretteselectronic cigarettes
electronic cigarettes
 
Examination of Sexually Dimorphic Behavior on the Novel-Image Novel-Location ...
Examination of Sexually Dimorphic Behavior on the Novel-Image Novel-Location ...Examination of Sexually Dimorphic Behavior on the Novel-Image Novel-Location ...
Examination of Sexually Dimorphic Behavior on the Novel-Image Novel-Location ...
 
Drug abuse and society drug presentations: Spring 2013
Drug abuse and society drug presentations: Spring 2013Drug abuse and society drug presentations: Spring 2013
Drug abuse and society drug presentations: Spring 2013
 
Sedative & Hypnotic Drugs Part II
Sedative & Hypnotic Drugs Part IISedative & Hypnotic Drugs Part II
Sedative & Hypnotic Drugs Part II
 
Sedative & Hypnotic Agents Part I
Sedative & Hypnotic Agents Part ISedative & Hypnotic Agents Part I
Sedative & Hypnotic Agents Part I
 
Agents for Bipolar
Agents for BipolarAgents for Bipolar
Agents for Bipolar
 
Psychopharmacology of Anxiety: Part II OCD & PTSD
Psychopharmacology of Anxiety: Part II OCD & PTSDPsychopharmacology of Anxiety: Part II OCD & PTSD
Psychopharmacology of Anxiety: Part II OCD & PTSD
 
Psychopharmacology of Anxiety Disorders I: GAD & SAD
Psychopharmacology of Anxiety Disorders I: GAD & SADPsychopharmacology of Anxiety Disorders I: GAD & SAD
Psychopharmacology of Anxiety Disorders I: GAD & SAD
 
Anti Inflammation agents for CNS
Anti Inflammation agents for CNSAnti Inflammation agents for CNS
Anti Inflammation agents for CNS
 
Antidepressants Part II
Antidepressants Part IIAntidepressants Part II
Antidepressants Part II
 
Anticonvulsants Part II
Anticonvulsants Part IIAnticonvulsants Part II
Anticonvulsants Part II
 
Anticonvulsants Part I
Anticonvulsants Part IAnticonvulsants Part I
Anticonvulsants Part I
 
Agents for Brain Injury
Agents for Brain InjuryAgents for Brain Injury
Agents for Brain Injury
 
ADHD Drugs
ADHD DrugsADHD Drugs
ADHD Drugs
 
Pathophysiology: Myasthenia Gravis & Restless Leg Syndrome
Pathophysiology: Myasthenia Gravis & Restless Leg SyndromePathophysiology: Myasthenia Gravis & Restless Leg Syndrome
Pathophysiology: Myasthenia Gravis & Restless Leg Syndrome
 
Pathophysiology: Migraine & Headache
Pathophysiology: Migraine & HeadachePathophysiology: Migraine & Headache
Pathophysiology: Migraine & Headache
 
Pathophysiology: Alzheimer's Disease
Pathophysiology: Alzheimer's DiseasePathophysiology: Alzheimer's Disease
Pathophysiology: Alzheimer's Disease
 
Pathophysiology: Introduction to Neuropsychiatry
Pathophysiology: Introduction to Neuropsychiatry Pathophysiology: Introduction to Neuropsychiatry
Pathophysiology: Introduction to Neuropsychiatry
 

Antipsychotics I

  • 1. Antipsychotics I Brian J. Piper, Ph.D., M.S. piperbj@husson.edu February 4, 2013
  • 2. Goals • Pharmacy students should: – be familiar with the symptoms & health consequences of schizophrenia – be able to describe the mechanism(s) of action and adverse effects of first- generation antipsychotics
  • 3. Schizophrenia The Greek translation is schizein “split” and phren “mind” which refers to a split from reality. A group of severe disorders characterized by atypical: 1. Cognition 2. Behavior 3. Emotions NOT Multiple Personality Disorder
  • 4. Symptoms of Schizophrenia Positive symptoms: the presence of inappropriate behaviors delusions: thoughts hallucinations: auditory >>> visual > other disorganized talking: “word salad” movements Negative symptoms: the absence of appropriate behaviors flat affect: joy, anger, disgust anhedonia catatonia: waxy flexibility
  • 5. Example Patient Delusions of grandeur inappropriate beliefs about one’s self-worth or special powers Gerald (upto 2:30): http://www.youtube.com/watch?v=gGnl8dqEoPQ
  • 6. Epidemiology of Schizophrenia Frequency: 0.7% Sex: Males > Females (1.4:1) in # and severity Low SES (downward drift) Rule of thirds Comorbidity with depression & smoking Sources: Anna K. Kring
  • 7. History of Antipsychotics • 1953: an antihistamine agent (cholpromazine) is found to improve psychosis in schizophrenics • 1960-1970: identification of D2 blockade as the key mechanism, development of these first-generation of antipsychotic agents
  • 8. Dopamine System I • nigrostriatal: substania nigra (soma) to striatum (axons) Stahl, S. (2008). Essential Psychopharmacology, p. 330.
  • 9. Antipsychotics & Tardive Dyskinesia Chronic blockade of D2 receptors leads This may cause involuntary movements. them to up-regulate. tardive: slow or belated onset dyskinesia: presence of involuntary movements, tongue thrusts, lip smacking, eye blinking Potentially permanent! Example: 4:20 to 5:50: http://www.youtube.com/watch?v=QYYx1mZDpPw
  • 10. TD = Extrapyramidal Symptoms (Long-Term) Brodal (2010). The central nervous system. p. 83.
  • 11. Extrapyramidal Symptoms (Short-term) • Pseudo-Parkinsonism: – tremor – rigidity – bradykinesia • dystonia: involuntary muscle spasms – torticollis: abnormal head or neck position • akathisia: severe sensation of restlessness, strong desire to move Excellent Examples (0:30- 4:50-9:15): http://www.youtube.com/watch?v=WAg2iLEWVh0
  • 12. Dopamine Inhibits Acetylcholine Stahl, S. (2008). Essential Psychopharmacology, p. 338.
  • 13. D2 Inhibition & Increased ACh Stahl, S. (2008). Essential Psychopharmacology, p. 339.
  • 14. Solution: Anti-cholinergics Stahl, S. (2008). Essential Psychopharmacology, p. 339.
  • 15. Dopamine Inhibits Prolactin Consequences amenorrhea galactorhea ↓ sex interest gynecomastia Stahl, S. (2008). Essential Psychopharmacology, p. 334.
  • 16. Dopamine & Mood • Dopamine projections to nucleus accumbens • Increasing dopamine increases reward • anti-psychotics block this pathway
  • 17. Non-Selectivity of FGA Stahl, S. (2008). Essential Psychopharmacology, p. 338, 340.
  • 18. Haloperidol • MOA: D2 antagonist, α1 antagonist • Indications: acute psychosis/schizophrenia • Adverse Effects: extrapyramidal symptoms (EPS), hypotension
  • 19. Summary: Pros & Cons • FGAs have strong efficacy against + symptoms. • FGAs either do not help – symptoms or exacerbate them. • The primary concern with FGAs is long-term development of tardive dyskinesia although acute EPS impair the quality of life of schizophrenics. Stahl, S. (2008). Essential Psychopharmacology, p. 369.
  • 20. Terminology • Neuroleptic = major tranquilizer = antipsychotic • First Generation Antipsychotic = Typical = Conventional
  • 21. Reduced Lifespan (N = 5,036,662) Male Male Female Female Life Expectancy Years Life Years Lost Lost Expectancy All (Psychiatric 76.5 NA 80.9 NA History - ) Schizophrenia 57.8 18.7 64.6 16.3 Bipolar 62.9 13.6 68.8 12.1 Contributing Factors suicide, accident, homicides, self-care (diet/smoking), metabolic (?) Laursen (2011). Schizophrenia Research, 131, 101-104.

Hinweis der Redaktion

  1. Psychosis is the older terminology to refer to distorted or non-existent sense of reality.
  2. Tardive= slow or belated onset.
  3. A pair of protrusions (tracts) are most pronounced at upper medulla. The pyramids are less obvious in the lower medulla. EPS also includes akinesia (inability to initiate movement) & pseudo-Parkinson’s.
  4. “Neuroleptic drug-induced parkinsonism is phenomenologically identical to idiopathic parkinsonism. Both are characterized by the triad of tremor, rigidity, and bradykinesia. The tremor is rhythmical with a to and fro motion which is usually greater at rest. Rigidity is most easily examined in the limbs and perceived as a rachet-like resistance during passive motion. Bradykinesia is a reduction in spontaneous activity, such as mask-like facial expression, decreased associated arm movements while walking, and decreased ability to initiate movement”.
  5. Dopamine acts normally on D2 receptors in the striatum as in inhibitor to decrease the release of acetylcholine.
  6. Diphenhydramine is also a potent competitive antagonist of muscarinic cholinergic receptors.
  7. The tuberoinfundibular pathway refers to a population of dopamine neurons in the arcuate nucleus of the mediobasal hypothalamus (the 'tuberal region') that project to the median eminence (the 'infundibular region'). Dopamine released at this site regulates the secretion of prolactin from the anterior pituitary gland.
  8. Vental Tegmental Area has dopaminergic somas.
  9. Alpha1 blockade results in orthostatic hypotension. Anti-histamine can increase appetite resulting in weight gain.
  10. Haloperidol causes difficulty swallowing (dysphagia) which can increase likelihood of choking and aspiration pneumonia.